Article
Acute Myeloid Leukemia Stem Cells: The Challenges of Phenotypic Heterogeneity
12 Dec 2020
Abstract excerpt
Patients suffering from acute myeloid leukemia (AML) show highly heterogeneous clinical outcomes. Next to variabilities in patient-specific parameters influencing treatment decisions and outcome, this is due to differences in AML biology. In fact, different genetic drivers may transform variable cells of origin and co-exist with additional genetic lesions (e.g., as observed in clonal hematopoiesis) in a variety...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
